N@N

Market Maker Surveillance Report. CHK, GILD, JNJ, WFC, VZ, MNKD, Bearishly Biased Price Friction For Monday, April 8th 2013

^{Published on 2013-04-08 18:46:33 - WOPRAI}
 

April 8, 2013 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3923 companies with "abnormal" market making, 3137 companies with positive Friction Factors and 2244 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. Chesapeake Energy Corp (NYSE:CHK), GILEAD SCIENCES, INC. (NASDAQ:GILD), Johnson & Johnson (NYSE:JNJ), WELLS FARGO & COMPANY (NYSE:WFC), Verizon Communications Inc (NYSE:VZ), Mannkind Corp (NASDAQ:MNKD). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  CHK     $-0.080   -0.39%    3,782,656    40.49%    2,141,007    22.92%    1,641,649    Abnormal
  GILD    $-0.160   -0.34%    5,446,129    57.57%    4,007,808    42.37%    1,438,321    Abnormal
  JNJ     $-0.930   -1.13%    5,976,019    37.93%    4,193,016    26.61%    1,783,003    Abnormal
  WFC     $-0.360   -0.96%    7,136,749    35.54%    5,715,488    28.46%    1,421,261    Abnormal
  VZ      $-0.530   -1.07%    4,676,528    40.80%    3,343,757    29.18%    1,332,771    Abnormal
  MNKD    $-0.020   -0.53%    2,391,383    70.83%    982,513      29.10%    1,408,870    Abnormal

For example, the chart above shows CHK with 1,641,649 greater shares of buying than selling (NetVol) and the stock price was down $-0.08000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.

Chesapeake Energy Corp (NYSE:CHK) - Chesapeake Energy Corporation engages in the acquisition, exploration, development, and production of natural gas and oil properties in the United States. The company also offers marketing, midstream, drilling, and other oilfield services. It holds interests in various natural gas resources, including the Haynesville and Bossier Shales in northwestern Louisiana and East Texas; the Marcellus Shale in the northern Appalachian Basin of West Virginia and Pennsylvania; and the Barnett Shale in the Fort Worth Basin of north-central Texas. The company also holds interests in various liquids-rich resource plays located in South Texas, Ohio, Pennsylvania, northwestern Oklahoma, Texas Panhandle, southern Kansas, and Wyoming. As of December 31, 2012, it had interests in approximately 45,400 gross productive wells. The company s proved reserves comprise approximately 15.690 trillion cubic feet of natural gas equivalents. Chesapeake Energy Corporation was founded in 1989 and is headquartered in Oklahoma City, Oklahoma..

GILEAD SCIENCES, INC. (NASDAQ:GILD) - Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Complera/Eviplera, and Emtriva for the treatment of human immunodeficiency virus (HIV) infection in adults; Viread and Hepsera oral formulations for the treatment of chronic hepatitis B; Letairis, an oral formulation for pulmonary arterial hypertension; Ranexa, a tablet for chronic angina; Lexiscan/Rapiscan, a test that detects and characterizes coronary artery disease; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; Tamiflu, a capsule for the treatment and prevention of influenza A and B. The company also provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular macular degeneration. In addition, it has product candidates in various stages for the treatment of HIV, which include integrase single-tablet regimen Quad; Cobicistat and Elvitegravir in Phase III; and GS-7340 in Phase II, as well as for liver disease, which consist of GS-7977 in Phase III; GS-5885, GS-9451, and GS-6624 in Phase II; and GS-7340, GS-9620, and GS-9669 in Phase I. Further, the company s product candidates in various stages for the treatment of cardiovascular/metabolic diseases comprise Ranolazine in Phase III; and for the treatment of respiratory diseases consist of Aztreonam for inhalation solution in Phase III, as well as GS-6624 in Phase I. Additionally, it has product candidates in various stages for inflammation/oncology diseases that include GS-1101 in Phase III; GS-1101 and GS-6624 in Phase II; and GS-9973 in Phase I. The company was founded in 1987 and is headquartered in Foster City, California..

Johnson & Johnson (NYSE:JNJ) - Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women s health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VEND ME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey..

WELLS FARGO & COMPANY (NYSE:WFC) - Wells Fargo & Company provides retail, commercial, and corporate banking services. The company's Community Banking segment offers deposits, such as checking accounts, savings deposits, market rate accounts, individual retirement accounts, time deposits, and debit cards; and loan products, including lines of credit, auto floor plan lines, equity lines and loans, equipment and transportation loans, education loans, residential mortgage loans, and credit cards. This segment also provides equipment leases, real estate and other commercial financing, small business administration financing, venture capital financing, cash management, payroll services, retirement plans, health savings accounts, credit cards, merchant payment processing, and private label financing solutions, as well as purchases retail installment contracts. Its Wholesale Banking segment offers commercial loans and lines of credit, letters of credit, asset-based lending, equipment leasing, international trade facilities, trade financing, collection services, foreign exchange, treasury management, investment management, institutional fixed-income sales, interest rate, commodity and equity risk management, online/electronic products, and investment banking services. This segment also provides construction loans, land acquisition and development loans, secured and unsecured lines of credit, interim financing arrangements, rehabilitation loans, affordable housing loans and letters of credit, permanent loans for securitization, commercial real estate loan servicing, and real estate and mortgage brokerage services. The company's Wealth, Brokerage, and Retirement segment offers financial advisory, wealth management, brokerage, retirement, trust, and reinsurance services. As of February 25, 2013, it provided services through approximately 9,000 stores, 12,000 ATMs, the Internet, and offices in approximately in 35 countries. The company was founded in 1852 and is headquartered in San Francisco, California..

Verizon Communications Inc (NYSE:VZ) - Verizon Communications Inc., through its subsidiaries, provides communications, information and entertainment products and services to consumers, businesses, and governmental agencies worldwide. Its Verizon Wireless segment offers access to various wireless voice and data services comprising Internet access through smart phones and basic phones, and notebook computers and tablets; messaging services, which enable customers to send and receive text, picture, and video messages; and consumer-focused and business-focused multimedia applications. This segment also provides location-based services; global data services; HomeFusion Broadband, a high-speed Internet service for homes; other connection-related services, such as data access and value added services to support telemetry-type applications; and machine-to-machine services that support devices used in healthcare, manufacturing, utilities, distribution, and consumer products markets, as well as sells smart phones and basic phones, tablets, and other Internet access devices. The company s Wireline segment offers video services over its fiber-optic network; data Services comprising high-speed Internet and FiOS broadband data products, as well as local exchange capacity, managed, mobility, and security services; voice services, such as local exchange, regional, long distance, wire maintenance, and voice messaging services, as well as VoIP, and landline and wireless services; and local dial tone and broadband services to local, long distance, and other carriers. This segment also provides networking products and solutions, such as private Internet protocol services, and Ethernet access and ring services; and infrastructure and cloud services. As of February 27, 2013, it served 98 million retail connections. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was founded in 1983 and is based in New York, New York..

Mannkind Corp (NASDAQ:MNKD) - MannKind Corporation, a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate, AFREZZA inhalation powder, an ultra rapid-acting insulin therapy that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MKC1106-MT, an investigational cancer immunotherapy product, which is in Phase II clinical trials; and MKC204, which is in preclinical development stage for the treatment of malignancies and inflammatory diseases. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net